Events

Event

/ / Event

GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for common chronic diseases. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.